Transcat, Inc.
TRNSIndustrialsNASDAQSpecialty Business Services
Scan Results
Daily timeframeTranscat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. At a $821.0M market cap, Transcat, Inc. ranks as a small-cap company within industrials. The company operates through two segments: Service and Distribution.
Market Cap
$821.0M
Beta
0.68
P/E (TTM)
156.96
P/E (Fwd)
41.03
EPS (TTM)
$0.56
EPS (Fwd)
$2.14
ROE
1.8%
ROA
2.3%
Cash
$4.9M
Total Debt
$133.3M
Free CF
$21.1M
52W Change
8.1%
Annual Financials
Cash vs Debt
On the balance sheet, TRNS has $4.9M in cash with $133.3M in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Free cash flow comes in at $21.1M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of 1.8% points to modest capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 2.3% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $205.0M (2022) to $331.9M (2026), reflecting a 62% increase over the period.
The relatively low beta of 0.68 suggests TRNS is a less volatile holding compared to the broader index. Transcat, Inc. carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. At over 50x earnings, TRNS carries valuation risk — any slowdown in growth expectations could lead to meaningful price adjustments. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing TRNS.